Tanking Biotech Stocks Will Imply a Large Year for Offers. Who Could Advantage.
Virtually two years following biotechnology shares began to tumble, executives at modest and midsize corporations in the room are lastly ...
Read moreDetails
Tag: CINC
CinCor Pharma Stock Surges on Offer to Be Obtained by AstraZeneca
AstraZeneca agreed to acquire U.S. biotech firm CinCor Pharma in a deal perhaps valued at $1.8 billion, the British pharmaceutical ...
Read moreDetails
CinCor, Albireo, Macy’s, Alibaba, and More Stock Market Movers Monday
We've detected you are on Internet Explorer. For the best Barrons.com experience, please update to a modern browser. We've detected ...
Read moreDetailsCinCor Pharma Inventory Surges on Deal to Be Obtained by AstraZeneca
AstraZeneca agreed to invest in U.S. biotech enterprise CinCor Pharma in a offer perhaps valued at $1.8 billion, the British ...
Read moreDetails